Influence of Ca2+ ions on the activity of lantibiotics containing a mersacidin-like lipid II binding motif

Applied and Environmental Microbiology

Volumn 75, Issue 13, 2009, Pages 4427-4434

  Bottiger T ^a   Schneider, T ^a   Martinez B ^b   Sahl, H G ^a   Wiedemann, I ^a  

^a UNIVERSITY OF BONN   (Germany)

^b DEPARTMENT OF MICROBIOLOGY AND BIOCHEMISTRY OF DAIRY PRODUCTS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI-MICROBIAL ACTIVITY; BACTERIAL MEMBRANES; BINDING MOTIF; CELL WALL BIOSYNTHESIS; LACTICIN; LANTIBIOTICS; MODE OF ACTION; STIMULATING EFFECTS; TRANSGLYCOSYLATION;

AMINES; BIOCHEMICAL ENGINEERING; BIOCHEMISTRY; CELL MEMBRANES; IONS;

CALCIUM;

BACTERIOCIN; CALCIUM CHLORIDE; CALCIUM ION; EGTAZIC ACID; LACTICIN 3147; LACTICIN 481; LANTIBIOTIC; LIPID; MAGNESIUM CHLORIDE; MERSACIDIN; NISIN; PEPTIDOGLYCAN; PLANTARICIN C; POTASSIUM; UNCLASSIFIED DRUG;

ANTIBIOTICS; ANTIMICROBIAL ACTIVITY; BACTERIUM; CALCIUM; CATION; LIPID; PEPTIDE;

ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL CELL WALL; BACTERIUM CULTURE; BIOSYNTHESIS; COLONY FORMING UNIT; CONTROLLED STUDY; DRUG ISOLATION; DRUG MECHANISM; DRUG STRUCTURE; GLYCOSYLATION; ISOTOPE LABELING; LACTOCOCCUS LACTIS; MICROCOCCUS LUTEUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PEPTIDE ANALYSIS; PROTEIN LIPID INTERACTION; STAPHYLOCOCCUS AUREUS;

AMINO ACID SEQUENCE; ANTI-BACTERIAL AGENTS; BACTERIOCINS; CALCIUM; ENZYME ACTIVATORS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PEPTIDES; URIDINE DIPHOSPHATE N-ACETYLMURAMIC ACID;

BACTERIA (MICROORGANISMS);

EID: 67649624728     PISSN: 00992240     EISSN: 10985336     Source Type: Journal    
DOI: 10.1128/AEM.00262-09     Document Type: Article

References (50)

1. Asaduzzaman, S. M., J. Nagao, Y. Aso, J. Nakayama, and K. Sonomoto. 2006. Lysine-oriented charges trigger the membrane binding and activity of nukacin ISK-1. Appl. Environ. Microbiol. 72:6012-6017.
2. Barrett, M. S., R. P. Wenzel, and R. N. Jones. 1992. In vitro activity of mersacidin (M87-1551), an investigational peptide antibiotic tested against gram-positive bloodstream isolates. Diagn. Microbiol. Infect. Dis. 15:641-644.
3. Bierbaum, G., and H. G. Sahl. 2009. Lantibiotics: mode of action, biosynthesis and bioengineering. Curr. Pharm. Biotechnol. 10:2-18.
4. Bonelli, R. R., T. Schneider, H. G. Sahl, and I. Wiedemann. 2006. Insights into in vivo activities of lantibiotics from gallidermin and epidermin mode-of-action studies. Antimicrob. Agents Chemother. 50:1449-1457.
5. Bouhss, A., A. E. Trunkfield, T. D. Bugg, and D. Mengin-Lecreulx. 2008. The biosynthesis of peptidoglycan lipid-linked intermediates. FEMS Microbiol. Rev. 32:208-233.
6. Brötz, H., G. Bierbaum, K. Leopold, P. E. Reynolds, and H. G. Sahl. 1998. The lantibiotic mersacidin inhibits peptidoglycan synthesis by targeting lipid II. Antimicrob. Agents Chemother. 42:154-160.
7. Brötz, H., G. Bierbaum, P. E. Reynolds, and H. G. Sahl. 1997. The lantibiotic mersacidin inhibits peptidoglycan biosynthesis at the level of transglycosylation. Eur. J. Biochem. 246:193-199.
8. Brötz, H., M. Josten, I. Wiedemann, U. Schneider, F. Götz, G. Bierbaum, and H. G. Sahl. 1998. Role of lipid-bound peptidoglycan precursors in the formation of pores by nisin, epidermin and other lantibiotics. Mol. Microbiol. 30:317-327.
9. Cooper, L. E., A. L. McClerren, A. Chary, and W. A. van der Donk. 2008. Structure-activity relationship studies of the two-component lantibiotic haloduracin. Chem. Biol. 15:1035-1045.
10. Cotter, P. D., L. H. Deegan, E. M. Lawton, L. A. Draper, P. M. O'Connor, C. Hill, and R. P. Ross. 2006. Complete alanine scanning of the two-component lantibiotic lacticin 3147: generating a blueprint for rational drug design. Mol. Microbiol. 62:735-747.
11. Cotter, P. D., L. A. Draper, E. M. Lawton, O. McAuliffe, C. Hill, and R. P. Ross. 2006. Overproduction of wild-type and bioengineered derivatives of the lantibiotic lacticin 3147. Appl. Environ. Microbiol. 72:4492-4496.
12. Cotter, P. D., C. Hill, and R. P. Ross. 2005. Bacteriocins: developing innate immunity for food. Nat. Rev. Microbiol. 3:777-788.
13. Counter, F. T., N. E. Allen, D. S. Fukuda, J. N. Hobbs, J. Ott, P. W. Ensminger, J. S. Mynderse, D. A. Preston, and C. Y. Wu. 1990. A54145 a new lipopeptide antibiotic complex: microbiological evaluation. J. Antibiot. (Tokyo) 43:616-622.
14. Cowgill, R. W. 1967. Fluorescence and protein structure. X. Reappraisal of solvent and structural effects. Biochim. Biophys. Acta 133:6-18.
15. Dufour, A., T. Hindré, D. Haras, and J. P. Le Pennec. 2007. The biology of lantibiotics from the lacticin 481 group is coming of age. FEMS Microbiol. Rev. 31:134-167.
16. Eliopoulos, G. M., C. Thauvin, B. Gerson, and R. C. Moellering, Jr. 1985. In vitro activity and mechanism of action of A21978C1, a novel cyclic lipopeptide antibiotic. Antimicrob. Agents Chemother. 27:357-362.
17. Eliopoulos, G. M., S. Willey, E. Reiszner, P. G. Spitzer, G. Caputo, and R. C. Moellering, Jr. 1986. In vitro and in vivo activity of LY 146032, a new cyclic lipopeptide antibiotic. Antimicrob. Agents Chemother. 30:532-535.
18. González, B., P. Arca, B. Mayo, and J. E. Suárez. 1994. Detection, purification, and partial characterization of plantaricin C, a bacteriocin produced by a Lactobacillus plantarum strain of dairy origin. Appl. Environ. Microbiol. 60:2158-2163.
19. Héchard, Y., and H. G. Sahl. 2002. Mode of action of modified and unmodified bacteriocins from Gram-positive bacteria. Biochimie 84:545-557. (Pubitemid 35350886)
20. Ho, S. W., D. Jung, J. R. Calhoun, J. D. Lear, M. Okon, W. R. Scott, R. E. Hancock, and S. K. Straus. 2008. Effect of divalent cations on the structure of the antibiotic daptomycin. Eur. Biophys. J. 37:421-433.
21. Hsu, S. T., E. Breukink, G. Bierbaum, H. G. Sahl, B. de Kruijff, R. Kaptein, N. A. van Nuland, and A. M. Bonvin. 2003. NMR study of mersacidin and lipid II interaction in dodecylphosphocholine micelles. Conformational changes are a key to antimicrobial activity. J. Biol. Chem. 278:13110-13117.
22. Hsu, S. T., E. Breukink, E. Tischenko, M. A. Lutters, B. de Kruijff, R. Kaptein, A. M. Bonvin, and N. A. van Nuland. 2004. The nisin-lipid II complex reveals a pyrophosphate cage that provides a blueprint for novel antibiotics. Nat. Struct. Mol. Biol. 11:963-967.
23. Jung, D., A. Rozek, M. Okon, and R. E. Hancock. 2004. Structural transitions as determinants of the action of the calcium-dependent antibiotic daptomycin. Chem. Biol. 11:949-957.
24. Kärcher, J. 2000. Mersacidin analoge Typ-B-Lantibiotika: Kristallisation, Datensammlung und Strukturaufklärung. Universität Göttingen, Göttingen, Germany.
25. Kuipers, O. P., H. S. Rollema, W. M. Yap, H. J. Boot, R. J. Siezen, and W. M. de Vos. 1992. Engineering dehydrated amino acid residues in the antimicrobial peptide nisin. J. Biol. Chem. 267:24340-24346.
26. Kuipers, O. P., W. M. G. J. Yap, H. S. Rollema, M. M. Beerthuyzen, R. J. Siezen, and W. M. de Vos. 1991. In G. Jung and H.-G. Sahl (ed.), Nisin and novel lantibiotics. ESCOM Science Publishers, Leiden, The Netherlands.
27. Mayer, L. D., M. J. Hope, and P. R. Cullis. 1986. Vesicles of variable sizes produced by a rapid extrusion procedure. Biochim. Biophys. Acta 858:161-168.
28. McAuliffe, O., M. P. Ryan, R. P. Ross, C. Hill, P. Breeuwer, and T. Abee. 1998. Lacticin 3147, a broad-spectrum bacteriocin which selectively dissipates the membrane potential. Appl. Environ. Microbiol. 64:439-445.
29. McClerren, A. L., L. E. Cooper, C. Quan, P. M. Thomas, N. L. Kelleher, and W. A. van der Donk. 2006. Discovery and in vitro biosynthesis of haloduracin, a two-component lantibiotic. Proc. Natl. Acad. Sci. USA 103:17243-17248.
30. Parisot, J., S. Carey, E. Breukink, W. C. Chan, A. Narbad, and B. Bonev. 2008. Molecular mechanism of target recognition by subtilin, a class I lanthionine antibiotic. Antimicrob. Agents Chemother. 52:612-618.
31. Patton, G. C., P. Moushumi, L. E. Cooper, C. Chatterjee, and W. A. van der Donk. 2008. The importance of the leader sequence for directing lanthionine formation in lacticin 481. Biochemistry 47:7342-7351. (Pubitemid 351991013)
32. Reisinger, P., H. Seidel, H. Tschesche, and W. P. Hammes. 1980. The effect of nisin on murein synthesis. Arch. Microbiol. 127:187-193.
33. Rick, P. D., G. L. Hubbard, M. Kitaoka, H. Nagaki, T. Kinoshita, S. Dowd, V. Simplaceanu, and C. Ho. 1998. Characterization of the lipid-carrier involved in the synthesis of enterobacterial common antigen (ECA) and identification of a novel phosphoglyceride in a mutant of Salmonella typhimurium defective in ECA synthesis. Glycobiology 8:557-567.
34. Rilla-Villar, N. 2003. Aplicación de bacterias lácticas productoras de bacteriocinas en bioconservación. Ph.D. thesis. Universidad de Santiago de Compostela, Santiago de Compostela, Spain.
35. Rouser, G., S. Fkeischer, and A. Yamamoto. 1970. Two dimensional thin layer chromatographic separation of polar lipids and determination of phospholipids by phosphorus analysis of spots. Lipids 5:494-496.
36. Sashihara, T., H. Kimura, T. Higuchi, A. Adachi, H. Matsusaki, K. Sonomoto, and A. Ishizaki. 2000. A novel lantibiotic, nukacin ISK-1, of Staphylococcus warneri ISK-1: cloning of the structural gene and identification of the structure. Biosci. Biotechnol. Biochem. 64:2420-2428.
37. Sauvage, E., F. Kerff, M. Terrak, J. A. Ayala, and P. Charlier. 2008. The penicillin-binding proteins: structure and role in peptidoglycan biosynthesis. FEMS Microbiol. Rev. 32:234-258.
38. Schneider, T., K. Gries, M. Josten, I. Wiedemann, S. Pelzer, H. Labischinski, and H. G. Sahl. 2009. The lipopeptide antibiotic friulimicin B inhibits cell wall biosynthesis through complex formation with bactoprenol-phosphate. Antimicrob. Agents Chemother. 53:1610-1618.
39. Schneider, T., M. M. Senn, B. Berger-Bächi, A. Tossi, H. G. Sahl, and I. Wiedemann. 2004. In vitro assembly of a complete, pentaglycine interpeptide bridge containing cell wall precursor (lipid II-Gly5) of Staphylococcus aureus. Mol. Microbiol. 53:675-685.
40. Smith, L., H. Hasper, E. Breukink, J. Novak, J. Čerkasov, J. D. Hillman, S. Wilson-Stanford, and R. S. Orugunty. 2008. Elucidation of the antimicrobial mechanism of mutacin 1140. Biochemistry 47:3308-3314.
41. Straus, S. K., and R. E. Hancock. 2006. Mode of action of the new antibiotic for Gram-positive pathogens daptomycin: comparison with cationic antimicrobial peptides and lipopeptides. Biochim. Biophys. Acta 1758:1215-1223.
42. Surewicz, W. K., and R. M. Epand. 1984. Role of peptide structure in lipid-peptide interactions: a fluorescence study of the binding of pentagastrin- related pentapeptides to phospholipid vesicles. Biochemistry 23:6072-6077. (Pubitemid 15153481)
43. Szekat, C., R. W. Jack, D. Skutlarek, H. Farber, and G. Bierbaum. 2003. Construction of an expression system for site-directed mutagenesis of the lantibiotic mersacidin. Appl. Environ. Microbiol. 69:3777-3783.
44. Uguen, P., T. Hindré, S. Didelot, C. Marty, D. Haras, J. P. Le Pennec, K. Vallée-Réhel, and A. Dufour. 2005. Maturation by LctT is required for biosynthesis of full-length lantibiotic lacticin 481. Appl. Environ. Microbiol. 71:562-565.
45. van Heijenoort, J. 2007. Lipid intermediates in the biosynthesis of bacterial peptidoglycan. Microbiol. Mol. Biol. Rev. 71:620-635.
46. Wiedemann, I., T. Böttiger, R. R. Bonelli, T. Schneider, H. G. Sahl, and B. Martínez. 2006. Lipid II-based antimicrobial activity of the lantibiotic plantaricin C. Appl. Environ. Microbiol. 72:2809-2814.
47. Wiedemann, I., T. Böttiger, R. R. Bonelli, A. Wiese, S. O. Hagge, T. Gutsmann, U. Seydel, L. Deegan, C. Hill, P. Ross, and H. G. Sahl. 2006. The mode of action of the lantibiotic lacticin 3147: a complex mechanism involving specific interaction of two peptides and the cell wall precursor lipid II. Mol. Microbiol. 61:285-296.
48. Wiedemann, I., E. Breukink, C. van Kraaij, O. P. Kuipers, G. Bierbaum, B. de Kruijff, and H. G. Sahl. 2001. Specific binding of nisin to the peptidoglycan precursor lipid II combines pore formation and inhibition of cell wall biosynthesis for potent antibiotic activity. J. Biol. Chem. 276:1772-1779.
49. Willey, J. M., and W. A. van der Donk. 2007. Lantibiotics: peptides of diverse structure and function. Annu. Rev. Microbiol. 61:477-501.
50. Xie, L., L. M. Miller, C. Chatterjee, O. Averin, N. L. Kelleher, and W. A. van der Donk. 2004. Lacticin 481: in vitro reconstitution of lantibiotic synthetase activity. Science 303:679-681. (Pubitemid 38141635)